We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$269M
AUM Growth
-$24.5M
Cap. Flow
-$35.3M
Cap. Flow %
-13.1%
Top 10 Hldgs %
26.19%
Holding
93
New
19
Increased
21
Reduced
26
Closed
25

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$8.51M
2
A icon
Agilent Technologies
A
+$6.74M
3
GILD icon
Gilead Sciences
GILD
+$6.48M
4
RVTY icon
Revvity
RVTY
+$6.21M
5
AET
Aetna Inc
AET
+$6.01M

Sector Composition

Rank Sector Weight
1 Healthcare 92.73%
2 Financials 1.34%
3 Energy 1.14%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGO icon
76
Perrigo
PRGO
$1.76B
-25,000
Closed -$2.12M
QGEN icon
77
Qiagen
QGEN
$8.9B
-56,583
Closed -$1.89M
RVTY icon
78
Revvity
RVTY
$12.9B
-90,000
Closed -$6.21M
TECH icon
79
Bio-Techne
TECH
$11.2B
-85,356
Closed -$2.58M
TMO icon
80
Thermo Fisher Scientific
TMO
$222B
-45,000
Closed -$8.51M
XRAY icon
81
Dentsply Sirona
XRAY
$2.34B
-35,000
Closed -$2.09M
HRC
82
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-50,000
Closed -$3.7M
VAR
83
DELISTED
Varian Medical Systems, Inc.
VAR
-41,683
Closed -$4.17M
CBM
84
DELISTED
Cambrex Corporation
CBM
-24,039
Closed -$1.32M
ATHN
85
DELISTED
Athenahealth, Inc.
ATHN
-12,000
Closed -$1.49M
IPXL
86
DELISTED
Impax Laboratories, Inc.
IPXL
-165,000
Closed -$3.35M
KITE
87
DELISTED
Kite Pharma, Inc.
KITE
-8,000
Closed -$1.44M

Similar funds

Sivik Global Healthcare's Q4 2017 Portfolio in Review

As of Q4 2017, Sivik Global Healthcare held 93 positions worth $269M, down 8.3% from $294M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sivik Global Healthcare withdrew a net $35.3M in Q4 2017, closing 25 positions and reducing 26 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $8.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 87% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in HCA Healthcare worth $7.47M.

  • Sivik Global Healthcare's largest Q4 2017 buy was HCA Healthcare: 85,000 shares worth $7.47M.
  • Sivik Global Healthcare added most to Teva Pharmaceuticals in Q4 2017, an estimated $2.63M increase.
  • Sivik Global Healthcare's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $6.01M.
  • Sivik Global Healthcare fully exited Thermo Fisher Scientific in Q4 2017, selling an estimated $8.51M.
  • Sivik Global Healthcare's ten largest holdings make up 26% of its $269M portfolio in Q4 2017.
  • Sivik Global Healthcare opened 19 new positions and closed 25 in Q4 2017.
  • Sivik Global Healthcare's portfolio value fell 8.3% quarter-over-quarter to $269M.

Based on Sivik Global Healthcare's 13F filing for Q4 2017, filed 8 Feb 2018.